Eli Lilly’s Verzenio Picks Up Third Approved Indication Post author:Sam Post published:February 26, 2018 Post category:BioPharma Eli Lilly snagged regulatory approval for expanded use of cancer treatment Verzenio. Source: BioSpace You Might Also Like This is the Average Interview Process Time for a Biopharma Job November 8, 2017 A Win for venBio as Judge Hits Pause on Immunomedics's $2 Billion Deal With Seattle Genetics March 9, 2017 Why Pfizer's 2017 Was Mediocre at Best December 12, 2017
A Win for venBio as Judge Hits Pause on Immunomedics's $2 Billion Deal With Seattle Genetics March 9, 2017
